THE SELECTIVE PROTECTION AFFORDED BY EBSELEN AGAINST LIPID-PEROXIDATION IN AN ROS-DEPENDENT MODEL OF INFLAMMATION

被引:21
作者
GRIFFITHS, HR
DOWLING, EJ
SAHINOGLU, T
BLAKE, DR
PARNHAM, M
LUNEC, J
机构
[1] A NATTERMANN & CIE,PHARMACOL RES,W-5000 COLOGNE,GERMANY
[2] UNIV LONDON LONDON HOSP,COLL MED,JOINT RES UNIT,LONDON E1 2AD,ENGLAND
来源
AGENTS AND ACTIONS | 1992年 / 36卷 / 1-2期
关键词
D O I
10.1007/BF01991237
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The effects of an experimental model of hydrogen-peroxide-induced foot pad oedema on indices of oxidative damage to biomolecules have been investigated. We have demonstrated increased levels of fluorescent protein and lipid peroxides occurring in plasma at 24 and 48 h post-injection. In addition, a decrease in the degree of galactosylation of IgG was observed which kinetically related the degree of inflammation and to the increase in protein autofluorescence (a specific index of oxidative damage). The effects of ebselen, a novel organoselenium compound which protects against oxidative tissue injury in a glutathione-peroxidase-like manner, have also been examined in this model. Pretreatment of animals with a dose of 50 mg/kg ebselen afforded significant and selective protection against lipid peroxidation only. This effect may contribute to the anti-inflammatory effect of this agent in hydroperoxide-linked tissue damage.
引用
收藏
页码:107 / 111
页数:5
相关论文
共 15 条
[1]  
[Anonymous], 1990, METABOLIC MOL BASIS
[2]  
AXFORD JS, 1987, LANCET, V2, P1486
[3]  
DOWLING EJ, 1989, J LEUKOCYTE BIOL, V46, P336
[4]   AGALACTOSYL IGG IN INFLAMMATORY BOWEL-DISEASE - CORRELATION WITH C-REACTIVE PROTEIN [J].
DUBE, R ;
ROOK, GAW ;
STEELE, J ;
BREALEY, R ;
DWEK, R ;
RADEMACHER, T ;
LENNARDJONES, J .
GUT, 1990, 31 (04) :431-434
[5]  
GRIFFITH HR, 1988, FREE RADICALS CHEM P, P439
[6]   THE EFFECTS OF OXYGEN FREE-RADICALS ON THE CARBOHYDRATE MOIETY OF IGG [J].
GRIFFITHS, HR ;
LUNEC, J .
FEBS LETTERS, 1989, 245 (1-2) :95-99
[7]  
GRIFFITHS HR, 1989, BRIT J RHEUM S, V228, P9
[8]   OXIDANTS, INFLAMMATION, AND ANTI-INFLAMMATORY DRUGS [J].
HALLIWELL, B ;
HOULT, JR ;
BLAKE, DR .
FASEB JOURNAL, 1988, 2 (13) :2867-2873
[9]  
JONES A F, 1987, British Journal of Cancer, V55, P60
[10]  
LUNEC J, 1985, J CLIN INVEST, V76, P2085